Shields Health Solutions, Welsh, Carson, Anderson & Stowe (“WCAS”) and Walgreen Co. (“Walgreens”) today announced the parties have entered into a definitive agreement through which WCAS and Walgreens will make equity investments in Shields.
Shields, the nation’s leader in patient-centric, integrated, hospital-owned specialty pharmacy care is taking on the investments as Shields continues to accelerate its national expansion. Shields currently partners with a network of more than 30 leading health systems nationwide to create on site, health system-owned specialty pharmacy programs, providing tightly integrated care management across more than 30 complex specialty disease states, including oncology, neurology, rheumatology and diabetes.
Let's Get To Work